676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational status is associated with a higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: What do we tell patients?
    Editorial

    Lee, M. K.; Robson, M. E.
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Biospecimen repositories in low- and middle-income countries: Insights from an American University of Beirut and Memorial Sloan Kettering collaboration
    Journal Article

    Faraj, W.; Robson, M.; Tawil, A.; Reuter, V.; Mahfouz, R.; Cambria, R.; Saheb, N.; Ferrer, C. S.; Vemuri, S.; Yaghi, M.; more...
    JCO Global Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
    Journal Article

    Nagaraj, G.; Vinayak, S.; Khaki, A. R.; Sun, T.; Kuderer, N. M.; Aboulafia, D. M.; Acoba, J. D.; Awosika, J.; Bakouny, Z.; Balmaceda, N. B.; more...
    eLife (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease
    Miscellaneous

    Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Miscellaneous

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease
    Journal Article

    Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study
    Journal Article

    Turner, N. C.; Laird, A. D.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; BalmanĖƒa, J.; Fasching, P. A.; more...
    npj Breast Cancer (2023)

    Fulltext@MSK | Save
  • BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer
    Meeting Abstract

    Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
    Journal Article

    Morra, A.; Schreurs, M. A. C.; Andrulis, I. L.; Anton-Culver, H.; Augustinsson, A.; Beckmann, M. W.; Behrens, S.; Bojesen, S. E.; Bolla, M. K.; Brauch, H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save